Palisade Asset Management, LLC reports 0.86% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Palisade Asset Management, LLC
Latest Disclosed Ownership	15,679 shares
Latest Disclosed Value	$ 950,932

On April 14, 2026 - Palisade Asset Management, LLC filed a 13F-HR form disclosing ownership of 15,679 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $821,893 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 15,815 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.86% during the quarter. The current value of the position is $743,655 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-14	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,679	-136	-0.86	951	11.37	0.0955
2026-02-13	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,815	-1,031	-6.12	853	12.38	0.0832
2025-11-17	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	16,846	-739	-4.20	760	-6.76	0.0706
2025-08-07	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	17,585	-2,600	-12.88	814	-33.87	0.0810
2025-04-23	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,185	-130	-0.64	1,231	7.14	0.1265
2025-02-11	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,315	280	1.40	1,149	10.91	0.1166
2024-11-12	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,035	1,926	10.64	1,037	37.77	0.1015
2024-08-02	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	18,109	-1,454	-7.43	752	-29.06	0.0778
2024-05-01	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	19,563	225	1.16	1,061	6.85	0.1033
2024-02-06	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	19,338	-2,348	-10.83	992	-21.14	0.1088
2023-11-07	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,686	760	3.63	1,259	-5.98	0.1530
2023-08-08	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,926	145	0.70	1,338	-7.08	0.1552
2023-05-10	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,781	-184	-0.88	1,440	-4.51	0.1765
2023-02-07	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,965	27	0.13	1,508	1.34	0.1728
2022-11-09	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,938	11	0.05	1,488	-7.64	0.2040
2022-08-05	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	20,927	-138	-0.66	1,611	4.75	0.2070
2022-04-21	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	21,065	4,450	26.78	1,538	48.46	0.1764
2022-02-01	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	16,615	-1,380	-7.67	1,036	-2.72	0.1159
2021-10-25	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	17,995	824	4.80	1,065	-7.15	0.1299
2021-07-22	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	17,171	437	2.61	1,147	8.62	0.1349
2021-05-04	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	16,734	935	5.92	1,056	7.76	0.1359
2021-02-03	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	15,799	0	0.00	980	2.83	0.1334
2020-10-26	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	15,799	225	1.44	953	4.04	0.1435
2020-07-27	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	15,574	-157	-1.00	916	4.45	0.1461
2020-04-24	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	15,731	510	3.35	877	-10.24	0.1599
2020-01-16	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	15,221	1,621	11.92	977	41.59	0.1429
2019-10-16	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	13,600	700	5.43	690	17.95	0.1052
2019-07-25	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	12,900	480	3.86	585	-1.35	0.0908
2019-04-15	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	12,420	1,450	13.22	593	4.04	0.0939
2019-01-16	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	10,970	325	3.05	570	-13.77	0.0836
2018-10-19	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	10,645	0	0.00	661	12.22	0.0874
2018-07-26	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	10,645	850	8.68	589	-5.00	0.0851
2018-04-25	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	9,795	-100	-1.01	620	2.31	0.0937
2018-02-01	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	9,895	0	0.00	606	-3.96	0.0959
2017-11-02	2017-09-30	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	9,895	1,425	16.82	631	33.69	0.1147
2017-10-26	2017-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,020	550		575
2017-08-01	2017-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,470	0	0.00	472	2.39	0.0926
2017-04-27	2017-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,470	0	0.00	461	-6.87	0.0847
2017-02-01	2016-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,470	-1,587	-15.78	495	-8.67	0.0949
2016-10-20	2016-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,057	0	0.00	542	-26.76	0.1009
2016-07-12	2016-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,057	-625	-5.85	740	8.50	0.1399
2016-04-14	2016-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,682	850	8.65	682	0.89	0.1321
2016-02-29	2015-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,832	-1,138	-10.37	676	4.16	0.1449
2015-10-21	2015-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,970	0	0.00	649	-11.10	0.1451
2015-07-13	2015-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,970	-199	-1.78	730	1.39	0.1453
2015-04-10	2015-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,169	1,200	12.04	720	22.45	0.1416
2015-01-16	2014-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,969	0	0.00	588	15.29	0.1157
2014-10-09	2014-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,969	0	0.00	510	5.37	0.1047
2014-07-25	2014-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,969	0	0.00	484	-6.56	0.1016
2014-04-22	2014-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,969	0	0.00	518	-2.26	0.1137
2014-02-04	2013-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,969	-1,801	-15.30	530	-2.75	0.1200
2013-10-25	2013-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	11,770	-1,550	-11.64	545	-8.40	0.1389
2013-08-02	2013-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,320	13,320		595		0.1498

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.